← Back to Search

Expressive Writing for PTSD and Alcohol Abuse (QueST2023 Trial)

N/A
Waitlist Available
Led By Jillian R Scheer, PhD
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-intervention), immediate post-intervention (1 week post first treatment session), and three-month follow-up (3 months post first treatment session)

Summary

This trial will test if online writing interventions can help reduce PTSD symptoms and hazardous drinking in sexual minority women, transgender individuals, and/or nonbinary people.

Who is the study for?
This trial is for sexual minority women, transgender individuals, and nonbinary people living in the US who are at least 18 years old. Participants must have internet access, speak English fluently, and have experienced a traumatic event. They should not have had inpatient psychiatric care recently.
What is being tested?
The study tests online writing interventions aimed at reducing PTSD symptoms and hazardous drinking among queer survivors of trauma. It compares Trauma Expressive Writing and Stigma Expressive Writing against a control group.
What are the potential side effects?
Since this trial involves expressive writing exercises rather than medical treatments or drugs, traditional physical side effects are not expected; however emotional discomfort due to recalling traumatic events may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-intervention), immediate post-intervention (1 week post first treatment session), and three-month follow-up (3 months post first treatment session)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-intervention), immediate post-intervention (1 week post first treatment session), and three-month follow-up (3 months post first treatment session) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in PTSD symptom severity
Change in drinking quantity
Change in hazardous drinking levels
+1 more
Secondary study objectives
Change in alexithymia
Change in attachment style.
Change in coping.
+16 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Trauma Expressive WritingExperimental Treatment1 Intervention
In the trauma condition, we ask participants to write about a traumatic experience, prompting them to write their very deepest thoughts and feelings about the most traumatic experience of their entire life or an extremely important stressful, upsetting, or emotional issue that has affected them.
Group II: Stigma Expressive WritingExperimental Treatment1 Intervention
In the stigma condition, we ask participants to write about an experience of stigma, prompting them to write about their very deepest thoughts and feelings about the most difficult or painful experience of stigma or bias (e.g., prejudice, bullying, rejection, discrimination) based on one or more of their identities (e.g., race/ethnicity, gender identity, sexual identity, religion) that they have faced.
Group III: ControlPlacebo Group1 Intervention
In the control condition, we ask participants to write about their day, prompting them to write about what they did yesterday from the time they got up until the time they went to bed.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalOTHER
3,000 Previous Clinical Trials
13,308,415 Total Patients Enrolled
5 Trials studying Alcohol Abuse
188 Patients Enrolled for Alcohol Abuse
Yale UniversityOTHER
1,912 Previous Clinical Trials
3,039,341 Total Patients Enrolled
6 Trials studying Alcohol Abuse
1,161 Patients Enrolled for Alcohol Abuse
Syracuse UniversityLead Sponsor
49 Previous Clinical Trials
117,581 Total Patients Enrolled
2 Trials studying Alcohol Abuse
1,103 Patients Enrolled for Alcohol Abuse

Media Library

Alcohol Abuse Research Study Groups: Stigma Expressive Writing, Trauma Expressive Writing, Control
Alcohol Abuse Clinical Trial 2023: Stigma Expressive Writing Highlights & Side Effects. Trial Name: NCT05569915 — N/A
Stigma Expressive Writing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05569915 — N/A
~8 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top